Brief: Sana Biotechnology Reports Fourth Quarter And 2020 Financial Results And Business Updates
March 24 (Reuters) - Sana Biotechnology Inc SANA.O :
* SANA BIOTECHNOLOGY REPORTS FOURTH QUARTER AND 2020
FINANCIAL
RESULTS AND BUSINESS UPDATES
* SANA BIOTECHNOLOGY INC - QTRLY LOSS PER SHARE BASIC AND
DILUTED
$7.40
* SANA BIOTECHNOLOGY INC - QTRLY ADJUSTED LOSS PER SHARE
$2.98
* SANA BIOTECHNOLOGY INC - CASH, CASH EQUIVALENTS AS OF DEC
31,
2020 WERE $412.0 MILLION COMPARED TO $139.0 MILLION AS OF DEC
31, 2019
Source text for Eikon: ID:nGNX51KkM9
Further company coverage: SANA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sana Biotechnology
See all newsSana Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Sana Biotechnology Q2 adjusted loss narrows, beats estimates
Brief: Sana Biotechnology Q2 Adjusted EPS USD -0.13 Vs. IBES Estimate USD -0.15
Sana Biotechnology posts Q1 adjusted loss narrower than expected, extends cash runway
Brief: Sana Biotechnology Q1 Adjusted EPS USD -0.14 Vs. IBES Estimate USD -0.17